ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Sloan-Kettering Creates Paul Marks Award; Weinberg, Hong Honored By M. D. Anderson.

February 18, 2000

In Brief: Breakthrough Prize Awarded to 11 Scientists

March 8, 2013

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

List Of NCI Divisions, Addresses And Telephone Numbers

October 13, 1995

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011